Skip to content

Rocker soles for the treatment of intermittent claudication

The efficacy of rocker soles in alleviating the symptoms of intermittent claudication: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN79785265
Enrollment
120
Registered
2008-06-04
Start date
2009-01-01
Completion date
Unknown
Last updated
2017-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intermittent claudication Musculoskeletal Diseases Other peripheral vascular diseases

Interventions

Volunteer claudicants will be recruited onto the study via attendance at the Lifestyle Management Clinic in the Vascular Department at Wirral University Teaching Hospitals NHS Trust, Wirral, England,

Sponsors

University of Salford (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Both males and females, over 18 years of age. There are no upper age limits 2. Those who have been diagnosed with stabilised intermittent claudication in one or both calf muscles 3. Ankle brachial pressure index of 0.8 or less 4. Those who have a maximum walking distance of between 10-300 m before having to stop walking due to their calf pain which is not being improved by other conservative interventions

Exclusion criteria

Exclusion criteria: Subjects with a history of lower limb joint replacement, cerebrovascular accident (CVA), or any orthopaedic or neurological impairment which adversely affects their gait or negates the fitting of stock therapeutic shoes

Design outcomes

Primary

MeasureTime frame
The following hospital-based walking trials will be held immediately before and after the two-week home trials: 1. Pain-free walking distance (PFWD) to the sudden onset of calf claudication pain 2. Overall intensity of calf claudication pain whilst claudicating 3. Maximum walking distance (MWD) before having to stop due to the intensity of the calf pain 4. Walking speed, step length and cadence

Secondary

MeasureTime frame
Quality of life (QOL) indicators using the intermittent claudication questionnaire (ICQ) before and after the two-week trial. It is anticipated that a future larger trial will be needed to provide statistically significant differences to QOL indicators, but this trial will give an indication and will inform the total number of recruits required in a subsequent trial study.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026